Tirzepatide Benefits
Reviewed by Fat Man in the Arena · Updated March 2026
How Tirzepatide works
Tirzepatide activates both the GIP and GLP-1 receptors simultaneously. This dual action enhances insulin secretion, reduces glucagon, slows gastric emptying, and reduces appetite through complementary pathways that neither receptor achieves alone.
Reported benefits
Based on published clinical trials, Tirzepatide has been associated with the following benefits:
- Average 20.9% body weight loss at highest dose (SURMOUNT-1)
- Greater weight loss than semaglutide in head-to-head trials
- Improved insulin sensitivity
- Reduced cardiovascular risk factors
- Better HbA1c reduction than semaglutide
Supporting research
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
New England Journal of Medicine, 2022 · PMID: 35658024
At the 15 mg dose, participants lost 20.9% of body weight over 72 weeks. More than half of participants at the highest dose lost over 20% of their weight.
Tirzepatide vs Semaglutide for Weight Loss (SURMOUNT-5)
New England Journal of Medicine, 2024 · PMID: 39652484
Tirzepatide 15 mg achieved 20.2% weight loss versus 13.7% with semaglutide 2.4 mg over 72 weeks in a direct head-to-head comparison.
Important context
Benefits reported in clinical trials represent average outcomes across study populations. Individual results vary based on genetics, dosage, duration, and lifestyle factors.
Related peptides
Weekly peptide research updates
New studies, GLP-1 news, protocol insights, and weight loss data — delivered every week. Free. No spam.